Showing 22,310 results

Filters Content type: Editors' picks
Global health targets

When Is a Nation’s HIV Epidemic Considered “Controlled”?

Editor's pick
Poz
8 November 2018
TB treatment

Pulmonary TB can be cured with shorter treatment, study finds

Editor's pick
Eurekalert Inf Dis
6 November 2018
People & personal stories

'Growing up, it felt like I was too gay to be black and too black to be gay'

Editor's pick
BBC
5 November 2018
PrEP programmes & uptake

Los Angeles PrEP outreach campaign targets at-risk women

Editor's pick
Daily Bulletin
5 November 2018
HIV & criminal law

Scottish hairdresser who tried to give gay partners HIV loses appeal against life sentence

Editor's pick
Daily Record
5 November 2018
Clinical trials

How to evaluate PrEP and vaccines: urgency for next generation compounds

Editor's pick
HIV i-Base
5 November 2018
Finance & funding

NAT calls for restoration of public health funding if Government is to realise its ambitions for prevention

Editor's pick
NAT
5 November 2018
Generic medicines

Gilead investors spooked by UnitedHealthcare push to cut HIV drug costs

Editor's pick
FiercePharma
5 November 2018
Epidemiology

HIV Rates Still Rising in Eastern Europe and Central Asia

Editor's pick
Medscape (requires free registration)
5 November 2018
Condoms & lubricant

Self-Lubricating Condom Shows Promise in Early Study

Editor's pick
Poz
5 November 2018
Drug-resistant TB

49th Union World Conference on Lung Health: 90 percent of participants in short-course XDR-TB regimen cured after six months

Editor's pick
Science Speaks
5 November 2018
TB transmission & prevention

49th Union World Conference on Lung Health: Integrating HIV treatment and TB preventative therapy greatly improves IPT adherence

Editor's pick
Science Speaks
5 November 2018
Pregnancy and vertical transmission

Malaysia eliminates HIV transmission from mother-to-child

Editor's pick
AVERT
5 November 2018
People & personal stories

Instagram's Aids memorial: ‘History does not record itself’

Editor's pick
The Guardian
5 November 2018
People & personal stories

'Nobody could make me laugh like you': Instagram memories of those lost to Aids

Editor's pick
The Guardian
5 November 2018
Injectable & long-acting HIV treatment

ViiV’s Long-Acting Injectable HIV Regimen Boasts Good 3-Year Results

Editor's pick
Poz
5 November 2018
Global health initiatives

Trump's State Department eyes ban on terms like 'sexual health'

Editor's pick
Politico
5 November 2018
PrEP science

PrEP Is Safe for Pregnant Women Who Want the HIV Prevention Drug, a New Study Finds

Editor's pick
The Body Pro
5 November 2018
Pregnancy and vertical transmission

Nigeria highest producer of HIV-infected babies

Editor's pick
Daily Post
5 November 2018
Ageing & HIV

Ageism And Sexuality

Editor's pick
Ageing Equal
5 November 2018
PrEP policies & guidelines

The NHS Refused To Give This Man The HIV Prevention Drug. He Got HIV.

Editor's pick
BuzzFeed
4 November 2018
Cardiovascular disease

Cardiovascular Risk Unclear for HIV Patients on Dolutegravir

Editor's pick
Medscape (requires free registration)
1 November 2018
Starting treatment

Janssen Presents Positive Long-Term Efficacy and Safety of SYMTUZA in Treatment-Naïve Adults with HIV-1

Editor's pick
Janssen press release
1 November 2018
Starting treatment

Gilead Announces 96-Week Results From Phase 3 Study of Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 in Adults New to HIV Therapy

Editor's pick
Gilead press release
1 November 2018